Longitudinal Change in Cognitive Function and Medication Adherence in HIV-Infected Adults

被引：0
作者：
Brian W. Becker
April D. Thames
Ellen Woo
Steven A. Castellon
Charles H. Hinkin
机构：
[1] VA Greater Los Angeles Health Care System,Neuropsychology Lab (256)
[2] David Geffen School of Medicine at UCLA,undefined
来源：
AIDS and Behavior | 2011年 / 15卷
关键词：
HIV; Medication adherence; HAART; Cognitive decline; Memory;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Neuropsychological (NP) dysfunction has been linked to poor medication adherence among HIV-infected adults. However, there is a dearth of research examining longitudinal changes in the relationship between NP status and adherence rates. We hypothesized that declines in NP functioning would be associated with a corresponding decline in medication adherence while stable NP functioning would be associated with stable or improving adherence rates. Participants included 215 HIV-infected adults who underwent cognitive testing at study entry and six months later. Compared to the NP stable group, the NP decline group showed a greater drop in adherence rates. Further analysis revealed that, beyond global NP, learning and memory was significantly associated with changes in adherence rates. These findings further support the link between cognitive functioning and medication adherence and illustrates the importance of documenting changes in cognitive abilities for identifying individuals at risk for poor adherence.
引用
收藏
相关论文
共 88 条
  • [1] Karon JM(1988)The projected incidence of AIDS and estimated prevalence of HIV infection in the United States J Acquir Immune Defic Syndr 1 542-550
  • [2] Dondero TJ(2001)Adolescent medicine HIV/AIDS research network. Antiretroviral medication adherence among the reach HIV-infected adolescent cohort in the USA AIDS Care. 13 27-40
  • [3] Curran JW(1999)Percentage of adherence correlates with the risk of protease inhibitor (PI) treatment failure in HIV-infected patients Antivir Ther 4 157-161
  • [4] Murphy DA(2007)Effect of adherence to HAART on virologic outcome and on the selection of resistance-conferring mutations in NNRTI- or PI-treated patients HIV Clin Trials. 8 282-292
  • [5] Wilson CM(2002)A prospective study of adherence and viral load in a large multi-center cohort of HIV-infected women AIDS. 16 2175-2182
  • [6] Durako SJ(2000)Adherence to protease inhibitors, HIV-1 viral load, and development off drug resistance in an indigent population AIDS. 14 357-366
  • [7] Muenz LR(2000)Adherence to protease inhibitor therapy and outcomes in patients with HIV infection Ann Intern Med. 133 21-30
  • [8] Belzer M(2001)Highly active antiretroviral therapy decreases mortality and morbidity in patients with advanced HIV disease Ann Intern Med. 135 17-26
  • [9] Casado JL(2001)Long-term quality of life outcomes in three antiretroviral treatment strategies for HIV-1 infection AIDS. 15 1985-1991
  • [10] Sabido R(2007)Drug use and medication adherence among HIV-1 infected individuals AIDS Behav 11 185-194
123456789